Chinese drugmaker fined $162M in antitrust case; Perrigo makes 2 animal-health deals in growth push;

@FiercePharma: German pricing watchdog didn't like Bayer's data on Eylea. No add'l benefit, IQWiG says. Bayer will respond. Report | Follow @FiercePharma

@EricPFierce: Greece urged to take new twist on compulsory licenses to get hands on cheaper drugs. Story | Follow @EricPFierce

> North China Pharmaceutical Group plans to appeal a $162 million fine on antitrust charges related to vitamin C exports to the U.S. Report (sub. req.)

> Two animal health acquisitions put over-the-counter drugmaker Perrigo in line to grow in that market and sell vet drugs in retail stores. Report

> Teva Pharmaceutical Industries ($TEVA) agreed to pay $2.3 million for violations of air and water pollution laws in Mexico, Missouri. Report

> Bayer sued Glenmark Pharmaceuticals after the Indian company asked FDA to approved its copycat version of Bayer's rosacea treatment Finacea. Report

> To fight a decline in pharma exports, Ireland needs to tweak its tax rules to make it even more attractive to drugmakers, an industry export told the Independent. Report

Medical Device News

 @FierceMedDev: Med tech incubator InCube Labs raises $30M in Texas expansion. More | Follow @FierceMedDev

 @MarkHFierce: The cosmetic laser industry is consolidating, in a deal that is pretty big (for the device industry. Release | Follow @MarkHFierce

 @DamianFierce: India wants to launch two independent committees to make sure clinical trials are ethical. Story | Follow @DamianFierce

> Will Panasonic sell its healthcare division for $1.05B? News

> FDA intensifies warning on Stryker's Neptune devices. More

> Molecular biosensor diagnoses cancer by spotting high lactate levels. Story

Biotech News

 @FierceBiotech: New special report: Biopharma's Top R&D Spenders - 2012. Report | Follow @FierceBiotech

@JohnCFierce: Updated AstraZeneca story. They buried the news on job cuts, thousands of relocations. Major upheaval. Story | Follow @JohnCFierce

@RyanMFierce: CRO buys chunk of mobile outfit behind virtual Pfizer trial. Article | Follow @RyanMFierce

> AstraZeneca axes more staffers, relocates thousands in global R&D reshuffle. Story

> FDA readies final decisions on four big biotech drugs. More

> Genomics player Illumina whacked with hefty patent case loss. Article

CRO News

> Sunshine Biopharma on the hunt for CMO partner. Item

> India deepens effort to regulate clinical trials. Article

> Ex-Aptuit researcher convicted of cooking Roche, AZ data. More

> BioClinica, CoreLab merge after buyouts. Report

> After CRO sell-off, Radiant doubles down on trial sites. Story

Biotech IT News

> CRO buys chunk of mobile outfit behind virtual Pfizer trial. Story

> BioClinica CEO: No cuts planned after CoreLab merger, private equity sale. Report

> Spiral Genetics scores $3M VC round from major backer. Item

> Novartis eyes cancer patients with two mobile apps for iPhone, Android. Article

> Genomic analysis startup scores VA contract for major study. More

And Finally... An Indian pharma company's warehouse was gutted in a fire after drums full of solvent sparked into flame. Report